The effect of goal-directed fluid therapy during esophageal cancer surgery on postoperative complications

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

CRIS

Registry ID

KCT0000617

Enrollment

120

Registered

2012-12-28

Start date

2013-01-02

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : Intrapoerative basal fluid replacement is realized in both groups with continuous infusion of 250 ml/hr of crystalloid solution. In the control group, the anesthesiologist is free to

and SVV < 12%) according to the goal-directed therapy protocol. Inotropes and vasopressor are also administered according to the goal-directed therapy protocol.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: - adult patients (20-80 yr) undergoing esophagectomy - elective surgery - patients who provide written informed consent

Exclusion criteria

Exclusion criteria: - age: 80 yr - pregnancy - emergency surgery - patients with atrial fibrillation - patients with liver cirrhosis - patients with severe aortic valve regurgitation - patients who refuse to enroll the study

Design outcomes

Primary

Measure	Time frame
postoperative complications (pneumonia, respiratory failure, myocardiac infaction, acute kidney injury, acute renal failure, in-hospital death etc.)	—

Secondary

Measure	Time frame
intensive care unit (ICU) stay;hospital stay	—

Countries

Korea, Republic of

Contacts

Public ContactDae-Kee Choi

Asan Medical Center

d001109@hanmail.net

Outcome results